Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients.
Nature 540 17 doi: 10.1038/540017a
Some of the most toxic refuse from modern society ends up in poor communities. Researchers are helping one area in the Middle East clean up its electronic-waste problem.
Nature 540 22 doi: 10.1038/540022a
Nature 's list of the key issues and appointments facing US government science agencies.
Nature News doi: 10.1038/nature.2016.21032
Scientists say mitochondrial-replacement therapy is ready for tests in the clinic.
Nature News doi: 10.1038/nature.2016.21067
Consortium backed by US National Institutes of Health is first major biology programme to mandate online publication of results ahead of peer review.
Nature News doi: 10.1038/nature.2016.21074
Illegal land clearing hits highest levels since 2008 as environmental policies come under attack.
Nature News doi: 10.1038/nature.2016.21083
British team is first to seek site of 1.5-million-year-old sample.
Nature 540 18 doi: 10.1038/540018a
Next generation of Trojan-horse drugs designed to minimize damage to healthy cells.
Nature 540 19 doi: 10.1038/540019a
Brussels-based advocacy group aimed to provide single voice for scientists in the EU – but is losing members.
Nature News doi: 10.1038/nature.2016.21064
Tom Price, Republican congressman from Georgia, has a thin track-record on science and research issues.
Nature News doi: 10.1038/nature.2016.21066
If politicians can lie without condemnation, what are scientists to do? Kathleen Higgins offers some explanation.
Nature 540 9 doi: 10.1038/540009a
Modified bacterial enzyme taught to make bonds that evolution avoids.
Nature News doi: 10.1038/nature.2016.21037
The week in science: 18–24 November 2016.
Nature 539 472 doi: 10.1038/539472a
Elaina Tuttle spent her life trying to understand the bizarre chromosome evolution of a common bird — until tragedy struck.
Nature 539 482 doi: 10.1038/539482a
Cash to include fund modelled on DARPA, the US defence department’s research arm — but how much will go to basic research is unclear.
Nature 540 16 doi: 10.1038/nature.2016.21038
String of publications describes attempts — mostly unsuccessful — to use proposed CRISPR rival.
Nature 540 20 doi: 10.1038/nature.2016.21023
The drug, and others based on the ‘amyloid hypothesis’, are still being tested in other, different trials.
Nature 540 15 doi: 10.1038/nature.2016.21045
Ahead of a key meeting on endocrine-disrupting chemicals, Leonardo Trasande argues that policy must follow the science.
Nature 539 469 doi: 10.1038/539469a
SESAME project is set to revolutionize science in the region but is strapped for cash.
Nature 539 475 doi: 10.1038/539475a
Worries include job prospects, discrimination — and safety.
Nature 539 476 doi: 10.1038/539476a